99 results on '"Badimon, Juan Jose"'
Search Results
2. Antithrombotic and prohemorrhagic actions of different concentrations of apixaban in patients exposed to single and dual antiplatelet regimens
3. Uncovering the Role of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction
4. Los iSGLT2 en la insuficiencia cardiaca. ¿Sus beneficios pueden extenderse a todo el espectro de la fracción de eyección?
5. Not only how much, but also how to, when measuring epicardial adipose tissue
6. Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study
7. Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment?
8. ¿Son los inhibidores del receptor SGLT2 fármacos antidiabéticos o cardiovasculares?
9. Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicity
10. Dual SGLT1 and SGLT2 inhibition: more than the sum of its parts
11. Inhibición dual del SGLT1 y SGLT2: algo más que su suma
12. Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the “Cardiac Benefits” of Empagliflozin Independent of its Hypoglycemic Activity?
13. HDL: un nuevo biomarcador para la insuficiencia cardiaca
14. Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial
15. Coronary Artery Disease in Aging Women: A Menopause of Endothelial Progenitor Cells?
16. Incremento de las HDL como arma terapéutica en la aterotrombosis
17. Increasing High-Density Lipoprotein as a Therapeutic Target in Atherothrombotic Disease
18. Importancia del colesterol HDL en la aterotrombosis. ¿De dónde venimos? ¿Hacia dónde vamos?
19. Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited?
20. Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis
21. Effects of electret coating technology on coronary stent thrombogenicity.
22. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
23. Genesis and Dynamics of Atherosclerotic Lesions: Implications for Early Detection
24. Platelet Glycoprotein IIb/IIIa Receptor Antagonists in Cardiovascular Disease
25. The vulnerable plaque and acute coronary syndromes
26. Rapamycin Inhibits Vascular Smooth Muscle Cell Migration
27. Antithrombotic effects of Abciximab
28. Catheter-based Renal Denervation as a Treatment for Pulmonary Hypertension: Hope or Hype?
29. Overcoming restenosis with sirolimus: from alphabet soup to clinical reality
30. Do the SGLT-2 Inhibitors Offer More than Hypoglycemic Activity?
31. High-Density Lipoprotein and Cardiovascular Risk Reduction: Promises and Realities
32. Differential inhibitory action of apixaban on platelet and fibrin components of forming thrombi: Studies with circulating blood and in a platelet-based model of thrombin generation.
33. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity.
34. Biologic aspects of vulnerable plaque.
35. Viewpoint Overcoming restenosis with sirolimus: from alphabet soup to clinical reality
36. Platelet Glycoprotein llb/llla Receptor Antagonists in Cardiovascular Disease.
37. Changes of plasma levels of apolipoproteins A-I, A-II, and B and their isoforms in patients with intestinal failure receiving long-term parenteral nutrition.
38. Radiotracers for Low Density Lipoprotein Biodistribution Studies In Vivo: Technetium-99m Low Density Lipoprotein Versus Radioiodinated Low Density Lipoprotein Preparations.
39. Potential applications of iontophoresis for local drug delivery of vascular diseases.
40. Coronary laser thermal angioplasty in the swine: reduced complications with shorter laser delivery time.
41. Platelet Interaction to Prosthetic Materials-Role of Von Willebrand Factor in Platelet Interaction to PTFE.
42. Reply
43. 1140-168 In vivo caspase-inhibition prevents plaque progression by reducing apoptosis and tissue-factor expression in a mouse model of chronic atherosclerosis
44. 1018-150 16-slice multidetector-row computed tomography and magnetic resonance imaging for the in vivo and noninvasive assessment of vessel areas and diameters
45. Increased circulating tissue factor and blood thrombogenicity in Type-2 diabetes
46. Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening
47. Platelet/Vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: Preventive strategies
48. Application of phospho-CyTOF to characterize immune activation in patients with sickle cell disease in an ex vivo model of thrombosis.
49. Pathogenetic concepts of acute coronary syndromes
50. CINE BALANCED STEADY-STATE FREE PRECESSION IS A RELIABLE ALTERNATIVE TO CONVENTIONAL T2-WEIGHTED IMAGING AND EVANS BLUE FOR THE CMR ASSESSMENT OF AREA AT RISK AFTER MYOCARDIAL INFARCTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.